Renal Cancer - Results from #2700

C-reactive protein at 1 month after treatment of nivolumab as a predictive marker of efficacy in advanced renal cell carcinoma. June 24, 2020

Identification of an Autophagy-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma. June 24, 2020

COVID-19 and Kidney Disease: Molecular Determinants and Clinical Implications in Renal Cancer. June 24, 2020

Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutation. June 23, 2020

Tivozanib in renal cell carcinoma: a new approach to previously treated disease. June 23, 2020

Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Disease-Free Survival in Post-Nephrectomy High-Risk Loco-Regional RCC: Analysis of the S-TRAC Trial. June 23, 2020

A Randomized Phase IIa Trial with Temsirolimus versus Sunitinib in Advanced Non-Clear Cell Renal Cell Carcinoma: An Intergroup Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and the Interdisciplinary Working Group on Renal C June 23, 2020

Renal cell carcinoma and COVID-19 pandemia: Management strategies adapted to current practice. June 23, 2020

The up-regulation of NDRG1 by HIF counteracts the cancer-promoting effect of HIF in VHL-deficient clear cell renal cell carcinoma. June 23, 2020

Identification of methylation-driven genes related to the prognosis of papillary renal cell carcinoma: a study based on The Cancer Genome Atlas. June 23, 2020

Consideration in the management of renal cell carcinoma during the COVID-19 Pandemic. June 22, 2020

Abdominoperineal resection with prostatectomy in T4 rectal cancer : bladder sparing robotic pelvic exenteration- video vignette. June 22, 2020

Novel therapies for advanced urologic cancers. June 19, 2020

Renal Tumors in Young Adults: Is Preoperative Computer Tomography Imaging Suggestive for the Nature of the Tumors? June 19, 2020

Survival After Surgery for Renal Cell Carcinoma Metastatic to the Spine: Impact of Modern Systemic Therapies on Outcomes. June 18, 2020

Impact of the systemic immune-inflammation index for the prediction of prognosis and modification of the risk model in patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors. June 18, 2020

Safety of sunitinib in patients with renal cell carcinoma following nephrectomy. June 17, 2020

A Population Study to Identify Candidates for Cytoreductive Nephrectomy in Patients with Metastatic Sarcomatoid Renal Cell Carcinoma from the Surveillance, Epidemiology, and End Results (SEER) Database. June 17, 2020

Clinical markers of morbidity, mortality and survival in bladder cancer patients treated with radical cystectomy. A systematic review. June 17, 2020

Optimizing patient selection for cytoreductive nephrectomy based on outcomes in the contemporary era of systemic therapy. June 16, 2020

Page 136 of 456